Here's the live share price of Bal Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Bal Pharma has gained 5.93% CAGR. Over the past year, the corresponding return has been -38.96%.
Bal Pharma’s current P/E of 17.27x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bal Pharma | 0.97 | -2.00 | -13.30 | -24.45 | -38.96 | -7.88 | 5.93 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Bal Pharma has declined 38.96% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Bal Pharma has underperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 73.36 | 73.79 |
| 10 | 73.4 | 73.7 |
| 20 | 73.84 | 74.39 |
| 50 | 78.12 | 77.67 |
| 100 | 83.46 | 82.69 |
| 200 | 90.7 | 90.12 |
In the latest quarter, Bal Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 0.23%, and public shareholding moved down to 48.91% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 13, 2025, 12:27 AM IST | Bal Pharma Ltd - Unaudited Financial Results For The Quarter Ended 30.09.2025 |
| Nov 13, 2025, 12:19 AM IST | Bal Pharma Ltd - Board Meeting Outcome for Outcome Of The Board Meeting_12.11.2025 |
| Nov 07, 2025, 8:31 PM IST | Bal Pharma Ltd - Update On The Outcome Of The Board Meeting Held On 11.08.2025 |
| Nov 04, 2025, 10:15 PM IST | Bal Pharma Ltd - Board Meeting Intimation for Unaudited Financial Results |
| Oct 06, 2025, 5:41 AM IST | Bal Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 302.50 Cr. and Equity Capital is Rs. 15.92 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bal Pharma is ₹74.04 as on Dec 24, 2025.
The Bal Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Bal Pharma is ₹117.88 Cr as on Dec 24, 2025.
Today’s highest and lowest price of Bal Pharma are ₹74.24 and ₹72.98.
The 52-week high/low is the highest and lowest price at which Bal Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bal Pharma is ₹131.45 and 52-week low of Bal Pharma is ₹70.20 as on Dec 24, 2025.
The Bal Pharma has shown returns of -0.15% over the past day, -2.0% for the past month, -13.3% over 3 months, -38.96% over 1 year, -7.88% across 3 years, and 5.93% over 5 years.
P/E ratio of and PB ratio of Bal Pharma are 17.27 and 1.50 on Dec 24, 2025. While the company gives a dividend yield of 1.62 per annum.